Published in Inflamm Bowel Dis on November 01, 2010
The new global map of human brucellosis. Lancet Infect Dis (2006) 12.83
Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis. Am J Gastroenterol (2004) 3.28
European evidence based consensus for endoscopy in inflammatory bowel disease. J Crohns Colitis (2013) 3.01
Association of Helicobacter pylori infection with cardiovascular disease--is it just a myth? Eur J Intern Med (2010) 1.67
A new simplified one port laparoscopic technique of peritoneal dialysis catheter placement with intra-abdominal fixation. Am J Surg (2006) 1.57
The edematogenic properties of insulin. Am J Kidney Dis (2004) 1.55
Octreotide in the treatment of refractory ascites of cirrhosis. Scand J Gastroenterol (2006) 1.55
Oxidative stress is progressively enhanced with advancing stages of CKD. Am J Kidney Dis (2006) 1.44
Increased fatigability of external anal sphincter in inflammatory bowel disease: significance in fecal urgency and incontinence. J Crohns Colitis (2010) 1.42
Thrombocytopenia associated with chronic liver disease: effects of rifaximin on platelet count. Am J Gastroenterol (2010) 1.41
Unexplained hypertransaminasaemia: clue to diagnosis of Addison's disease. Eur J Gastroenterol Hepatol (2002) 1.40
Effects of nitric oxide inhibition by methylene blue in cirrhotic patients with ascites. Dig Dis Sci (2005) 1.38
Predictors of early response to infliximab in patients with ulcerative colitis. Inflamm Bowel Dis (2007) 1.33
Spectrum and frequency of ophthalmologic manifestations in patients with inflammatory bowel disease: a prospective single-center study. Inflamm Bowel Dis (2009) 1.22
Lateral medullary ischaemic events in young adults with hypoplastic vertebral artery. J Neurol Neurosurg Psychiatry (2007) 1.17
Jaundice of unknown origin: Remember zoonoses! Scand J Gastroenterol (2006) 1.13
Doubling the infliximab dose versus halving the infusion intervals in Crohn's disease patients with loss of response. Inflamm Bowel Dis (2012) 1.08
On the probable association of adalimumab and diffuse retinopathy in a patient with Crohn's disease. J Crohns Colitis (2012) 1.06
Health literacy in the field of infectious diseases: the paradigm of brucellosis. J Infect (2006) 1.02
Role of genetics in the diagnosis and prognosis of Crohn's disease. World J Gastroenterol (2012) 1.01
Is vertebral artery hypoplasia a predisposing factor for posterior circulation cerebral ischemic events? A comprehensive review. Eur Neurol (2013) 1.01
The role of quality of care in health-related quality of life in patients with IBD. Inflamm Bowel Dis (2004) 1.01
The effects of chronic treatment with octreotide versus octreotide plus midodrine on systemic hemodynamics and renal hemodynamics and function in nonazotemic cirrhotic patients with ascites. Am J Gastroenterol (2005) 1.00
Rifaximin improves systemic hemodynamics and renal function in patients with alcohol-related cirrhosis and ascites. Clin Gastroenterol Hepatol (2012) 0.97
Effects of a 7-day treatment with midodrine in non-azotemic cirrhotic patients with and without ascites. J Hepatol (2006) 0.96
Neurologic manifestations in inflammatory bowel diseases: current knowledge and novel insights. J Crohns Colitis (2009) 0.95
Rectal Epstein-Barr virus-positive Hodgkin's lymphoma in a patient with Crohn's disease: case report and review of the literature. Scand J Gastroenterol (2006) 0.94
Rifaximin reduces endotoxemia and improves liver function and disease severity in patients with decompensated cirrhosis. Hepatology (2012) 0.93
Inflammatory bowel disease and lupus: a systematic review of the literature. J Crohns Colitis (2012) 0.92
Correction of anemia with erythropoietin in chronic kidney disease (stage 3 or 4): effects on cardiac performance. Cardiovasc Drugs Ther (2007) 0.91
Characteristics of ascitic fluid in cardiac ascites. Scand J Gastroenterol (2007) 0.90
Vertebral artery hypoplasia in posterior circulation cerebral ischemia. Clin Neurol Neurosurg (2012) 0.88
Interruption of triacylglycerol synthesis in the endoplasmic reticulum is the initiating event for saturated fatty acid-induced lipotoxicity in liver cells. FEBS J (2010) 0.88
Cancer in inflammatory bowel disease 15 years after diagnosis in a population-based European Collaborative follow-up study. J Crohns Colitis (2011) 0.87
Initial disease course and treatment in an inflammatory bowel disease inception cohort in Europe: the ECCO-EpiCom cohort. Inflamm Bowel Dis (2014) 0.87
A family report of Crohn's disease in three children immigrating from Albania to Greece and review of the literature. J Crohns Colitis (2010) 0.86
Electrocardiographic abnormalities and cardiac arrhythmias in structural brain lesions. Int J Cardiol (2012) 0.86
Brain involvement in patients with inflammatory bowel disease: a voxel-based morphometry and diffusion tensor imaging study. Eur Radiol (2014) 0.86
Immunohistochemical expression of Fhit protein in Helicobacter pylori related chronic gastritis, gastric precancerous lesions and gastric carcinoma: correlation with conventional clinicopathologic parameters. Eur J Gastroenterol Hepatol (2003) 0.86
Splenic marginal zone lymphoma in a patient with chronic hepatitis B. J Gastrointestin Liver Dis (2009) 0.85
Sjogren's syndrome in a patient with ulcerative colitis and primary sclerosing cholangitis: Case report and review of the literature. J Crohns Colitis (2009) 0.85
Costs and resource utilization for diagnosis and treatment during the initial year in a European inflammatory bowel disease inception cohort: an ECCO-EpiCom Study. Inflamm Bowel Dis (2015) 0.84
Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites. Nephrol Dial Transplant (2005) 0.84
Alarming atrioventricular block and mitral valve prolapse in the Kearns-Sayre syndrome. Int J Cardiol (2002) 0.84
Do we really understand what the immunological disturbances in inflammatory bowel disease mean? World J Gastroenterol (2009) 0.84
The effects of treatment with octreotide, diuretics, or both on portal hemodynamics in nonazotemic cirrhotic patients with ascites. J Clin Gastroenterol (2006) 0.84
Interaction between the polymorphisms of the renin-angiotensin system in preeclampsia. Eur J Obstet Gynecol Reprod Biol (2003) 0.83
Rifaximin improves thrombocytopenia in patients with alcoholic cirrhosis in association with reduction of endotoxaemia. Liver Int (2011) 0.83
Association of liver cirrhosis related IgA nephropathy with portal hypertension. World J Gastroenterol (2007) 0.83
New prognostic markers for outcome of acute pancreatitis: overview of reporting in 184 studies. Pancreas (2011) 0.83
Patients with psoriasis are more likely to be treated for latent tuberculosis infection prior to biologics than patients with inflammatory bowel disease. Acta Derm Venereol (2011) 0.82
Intravenous iron therapy restores functional iron deficiency induced by infliximab. J Crohns Colitis (2007) 0.82
Polymyalgia rheumatica associated with neck surgery. South Med J (2009) 0.82
Concurrent development of spontaneous pyomyositis due to Staphylococcus epidermidis and Kikuchi-Fujimoto disease. Intern Med (2008) 0.82
Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs. Am J Nephrol (2007) 0.82
Immunohistochemical expression of cyclin D1, cyclin E, p21/waf1 and p27/kip1 in inflammatory bowel disease: correlation with other cell-cycle-related proteins (Rb, p53, ki-67 and PCNA) and clinicopathological features. Int J Colorectal Dis (2004) 0.81
The impact of hemodialysis on the dispersion of ventricular repolarization. Pacing Clin Electrophysiol (2013) 0.81
Vascular access for haemodialysis in extreme situations: surgically placed inferior vena cava catheter. Nephrol Dial Transplant (2004) 0.81
Measurements of endothelin-1, C-reactive protein and fibrinogen plasma levels in patients with acute ischemic stroke. Neurol Res (2008) 0.81
Red face, postendoscopy. BMJ Case Rep (2011) 0.81
Hypouricemia in individuals admitted to an inpatient hospital-based facility. Am J Kidney Dis (2003) 0.81
Patient's age modifies the impact of the proposed predictors of sustained virological response in chronic hepatitis C patients treated with PEG-interferon plus ribavirin. Eur J Intern Med (2008) 0.81
Inflammatory bowel disease and hepatitis B and C in Western Balkans: a referral centre study and review of the literature. J Crohns Colitis (2010) 0.81
Acute Haemophilus parainfluenzae endocarditis: a case report. J Med Case Rep (2009) 0.80
Pseudomonas fluorescens infections in clinical practice. Scand J Infect Dis (2006) 0.80
Serological markers are associated with disease course in ulcerative colitis. A study in an unselected population-based cohort followed for 10 years. J Crohns Colitis (2007) 0.80
Small bowel adenocarcinoma presenting as a first manifestation of Crohn's disease: report of a case, and a literature review. Eur J Gastroenterol Hepatol (2002) 0.80
Racial disparities in early mortality in 1,134 young patients with acute stroke. Neurol Sci (2014) 0.80
Endotoxaemia in the pathogenesis of cytopenias in liver cirrhosis. Could oral antibiotics raise blood counts? Med Hypotheses (2010) 0.80
Non-toxic megacolon due to transverse and sigmoid colon volvulus in a patient with ulcerative colitis. J Crohns Colitis (2008) 0.80
Differential effects of terlipressin on pulmonary and systemic hemodynamics in patients with cirrhosis and pulmonary hypertension: an echo study. Angiology (2011) 0.80
Small bowel parasitosis as cause of obscure gastrointestinal bleeding diagnosed by capsule endoscopy. World J Gastrointest Endosc (2010) 0.79
Successful management of full-length obstructing esophageal bezoars in an intensive care unit. Intensive Care Med (2010) 0.79
Randomized phase II exploratory study of prophylactic amifostine in cancer patients who receive radical radiotherapy to the pelvis. J Exp Clin Cancer Res (2010) 0.79
Role of genetics in the diagnosis and prognosis of Crohn's disease. World J Gastroenterol (2011) 0.79
Weil's disease in a patient with chronic viral hepatitis and history of alcohol abuse. Intern Med (2008) 0.79
Changing serological status and low vaccination-induced protection rates against hepatitis B characterize chronic hepatitis C virus-infected injecting drug users in Greece: need for immunization policy. Eur J Gastroenterol Hepatol (2006) 0.79
Beneficial haemodynamic and renal sodium handling effects of combined midodrine and octreotide treatment in a cirrhotic patient with large hepatic hydrothorax and mild ascites. Nephrol Dial Transplant (2005) 0.79
Treatment of hepatic hydrothorax with vasoconstrictor drugs. Scand J Gastroenterol (2007) 0.79
Vasoconstrictor therapy for patients with cirrhosis with ascites but without hepatorenal syndrome. Hepatology (2008) 0.79
Silent ulcerative colitis adjacent to a regular sigmoid adenocarcinoma. Eur J Gastroenterol Hepatol (2011) 0.79
Orbital and optic nerve complications of inflammatory bowel disease. J Crohns Colitis (2012) 0.79
Inflammatory bowel disease and demyelination: more than just a coincidence? Expert Rev Clin Immunol (2014) 0.78
Long-term anticoagulation therapy for a cirrhotic patient with recurrent deep venous thrombosis. J Gastroenterol Hepatol (2005) 0.78
Tumor necrosis factor-alpha-related intraperitoneal release of CA 125 in cirrhotic patients with sterile ascites. Clin Chem (2005) 0.78
Effects of somatostatin, terlipressin and somatostatin plus terlipressin on portal and systemic hemodynamics and renal sodium excretion in patients with cirrhosis. J Gastroenterol Hepatol (2005) 0.78